We’re in the midst of the second holiday season of this pandemic, and as Americans, we have many reasons to be thankful. Among our top reasons for gratitude this year is that mass immunization has helped cut COVID-19 cases in half in the U.S. since summer’s peak. Nearly 200 million Americans are vaccinated, and we have ample supply on hand for youth and adults. However, the picture is not as bright in the developing world: As of October,
Moderna you would think has an especially strong reason to work with the US government to promote distribution of their vaccine. The NIH was at the very least crucial to the research that was behind the vaccine, but Moderna is focusing on profit at all points. They haven't received a patent on their vaccine because they are fighting with NIH over control of the crucial patient.
The extent to which Moderna is going to prioritize profits over public should be a problem, but most Pharma companies have learned that it really doesn't matter what the public may think of them.
Moderna is a private company and makes decisions for their company. It makes no business sense to giveaway formulas. The government cannot seem to do anything in an efficient or cost effective manner. Look at our national debt, the over spending year after year and Democrats tax tax tax. We should be thankful Moderna and Pfizer stepped forward.
It's not part of the pharmaceutical industry narrative, when we talk about "investment in innovation and research" to mention that government subsidies in the form of research grants or other more significant investments, are even part of the equation. When we talk about prescription drug prices, we only hear "Drug Companies need to charge a lot for prescription drugs to make back their R&D investment." We really need a much more balanced/nuanced discussion about drug costs and what can be done about them.
Moderna you would think has an especially strong reason to work with the US government to promote distribution of their vaccine. The NIH was at the very least crucial to the research that was behind the vaccine, but Moderna is focusing on profit at all points. They haven't received a patent on their vaccine because they are fighting with NIH over control of the crucial patient.
for instance see:
https://www.nature.com/articles/d41586-021-03535-x
The extent to which Moderna is going to prioritize profits over public should be a problem, but most Pharma companies have learned that it really doesn't matter what the public may think of them.
Moderna is a private company and makes decisions for their company. It makes no business sense to giveaway formulas. The government cannot seem to do anything in an efficient or cost effective manner. Look at our national debt, the over spending year after year and Democrats tax tax tax. We should be thankful Moderna and Pfizer stepped forward.
It's not part of the pharmaceutical industry narrative, when we talk about "investment in innovation and research" to mention that government subsidies in the form of research grants or other more significant investments, are even part of the equation. When we talk about prescription drug prices, we only hear "Drug Companies need to charge a lot for prescription drugs to make back their R&D investment." We really need a much more balanced/nuanced discussion about drug costs and what can be done about them.